Pathogenetic factors involved in recurrent pregnancy loss from multiple aspects

키워드

참고문헌 (102)

1. Krieg S, "Immune function and recurrent pregnancy loss", Semin Reprod Med, 33, pp.305~312 (2015)
2. Coulam CB, "Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Clinical guidelines recommendation committee for diagnosis and treatment of recurrent spontaneous abortion", Am J Reprod Immunol, 38, pp.57~74 (1997)
3. Practice Committee of the American Society for Reproductive Medicine, "Evaluation and treatment of recurrent pregnancy loss: a committee opinion", Fertil Steril, 98, pp.1103~1111 (2012)
4. Practice Committee of American Society for Reproductive Medicine, "Definitions of infertility and recurrent pregnancy loss : a committee opinion", Fertil Steril, 99, pp.63~ (2013)
5. Pan HT, "Proteomics and bioinformatics analysis of altered protein expression in the placental villous tissue from early recurrent miscarriage patients", Placenta, 61, pp.1~10 (2018)
6. Kim YS, "Proteomic analysis of recurrent spontaneous abortion : identification of an inadequately expressed set of proteins in human follicular fluid", Proteomics, 6, pp.3445~3454 (2006)
7. Kim MS, "ITI-H4, as a biomarker in the serum of recurrent pregnancy loss(RPL)patients", Mol Biosyst, 7, pp.1430~1440 (2011)
8. Li L, "Opposing roles of inter-α-trypsin inhibitor heavy chain 4 in recurrent pregnancy loss", EBioMedicine, 37, pp.535~546 (2018)
9. Tyers M, "From genomics to proteomics", Nature, 422, pp.193~197 (2003)
10. Jeon YJ, "Association between polymorphisms in the reninangiotensin system genes and prevalence of spontaneously aborted fetuses", Am J Reprod Immunol, 70, pp.238~245 (2013)
11. Bell CE, "Mitogen-activated protein kinase(MAPK)pathways mediate embryonic responses to culture medium osmolarity by regulating Aquaporin 3 and 9 expression and localization, as well as embryonic apoptosis", Hum Reprod, 24, pp.1373~1386 (2009)
12. Vergnes L, "Lamin B1 is required for mouse development and nuclear integrity", Proc Natl Acad Sci U S A, 101, pp.10428~10433 (2004)
13. Nagatomo H, "Requirement for nuclear autoantigenic sperm protein mRNA expression in bovine preimplantation development", Anim Sci J, 87, pp.457~461 (2016)
14. Stary M, "Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro", Exp Cell Res, 310, pp.331~343 (2005)
15. Stary M, "Parietal endoderm secreted S100A4 promotes early cardiomyogenesis in embryoid bodies", Biochem Biophys Res Commun, 343, pp.555~563 (2006)
16. Wang X, "Thoc1", Hpr1, Mol Cell Biol, pp.2006, 26[DOI]
17. Chávez S, "A protein complex containing Tho2, Hpr1, Mft1 and a novel protein, Thp2, connects transcription elongation with mitotic recombination in Saccharomyces cerevisiae", EMBO J, 19, pp.5824~5834 (2000)
18. Rehwinkel J, "Genome-wide analysis of mRNAs regulated by the THO complex in Drosophila melanogaster", Nat Struct Mol Biol, 11, pp.558~566 (2004)
19. Jakupoglu C, "Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development", Mol Cell Biol, 25, pp.1980~1988 (2005)
20. Brafman DA, "Regulation of endodermal differentiation of human embryonic stem cells through integrin-ECM interactions", Cell Death Differ, 20, pp.369~381 (2013)
21. Frésard L, "Epigenetics and phenotypic variability : some interesting insights from birds", Genet Sel Evol, 45, pp.16~ (2013)
22. Wu H, "Early embryos reprogram DNA methylation in two steps", Cell Stem Cell, 10, pp.487~489 (2012)
23. Blair JD, "Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia", Mol Hum Reprod, 19, pp.697~708 (2013)
24. Feinberg AP, "Phenotypic plasticity and the epigenetics of human disease", Nature, 447, pp.433~440 (2007)
25. Reamon-Buettner SM, "A new paradigm in toxicology and teratology : altering gene activity in the absence of DNA sequence variation", Reprod Toxicol, 24, pp.20~30 (2007)
26. Hanna CW, "DNA methylation profiling of placental villi from karyotypically normal miscarriage and recurrent miscarriage", Am J Pathol, 182, pp.2276~2284 (2013)
27. Yu M, "Integrated analysis of DNA methylome and transcriptome identified CREB5 as a novel risk gene contributing to recurrent pregnancy loss", EBioMedicine, 35, pp.334~344 (2018)
28. Long X, "MiR-582-5p", miR-590-5p targeted CREB1, Transl Psychiatry, pp.2016, 6[DOI]
29. Nevalainen T, "Transcriptomic and epigenetic analyses reveal a gender difference in agingassociated inflammation: the vitality 90+ study", Age(Dordr), 37, pp.9814~ (2015)
30. Williams LM, "Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3", Nat Immunol, 8, pp.277~284 (2007)
31. Wan YY, "Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3expression", Nature, 445, pp.766~770 (2007)
32. Hou W, "Correlation between protein expression of FOXP3 and level of FOXP3 promoter methylation in recurrent spontaneous abortion", J Obstet Gynaecol Res, 42, pp.1439~1444 (2016)
33. Cha J, "Mechanisms of implantation : strategies for successful pregnancy", Nat Med, 18, pp.1754~1767 (2012)
34. White MD, "How adhesion forms the early mammalian embryo", Curr Top Dev Biol, 112, pp.1~17 (2015)
35. Quintero-Ronderos P, "Novel genes and mutations in patients affected by recurrent pregnancy loss", PLoS One, 12, pp.e0186149~ (2017)
36. Sladek SM, "Nitric oxide and pregnancy", Am J Physiol, 272, pp.R441~R463 (1997)
37. Suryanarayana V, "Recurrent early pregnancy loss and endothelial nitric oxide synthase gene polymorphisms", Arch Gynecol Obstet, 274, pp.119~124 (2006)
38. Shin SJ, "Endothelial nitric oxide synthase gene polymorphisms(-786T>C, 4a4b, 894G>T)and haplotypes in Korean patients with recurrent spontaneous abortion", Eur J Obstet Gynecol Reprod Biol, 152, pp.64~67 (2010)
39. Azani A, "Association of endothelial nitric oxide synthase gene variants(-786 T>C, intron 4 b", a VNTR and 894 G>T)with idiopathic recurrent pregnancy loss : a case-control study with haplotype and in silico analysis, 2017, pp.215, 93~100
40. 류창수, "Association study of the three functional polymorphisms (TAS2R46G>A, OR4C16G>A, and OR4X1A>T) with recurrent pregnancy loss", Genes & Genomics, 41(1), pp.61~70 (2019), 한국유전학회[DOI]
41. Trowsdale J, "Mother’s little helpers : mechanisms of maternal-fetal tolerance", Nat Immunol, 7, pp.241~246 (2006)
42. Schjenken JE, "Mirna regulation of immune tolerance in early pregnancy", Am J Reprod Immunol, 75, pp.272~280 (2016)
43. Saito S, "Th1", Th2, Am J Reprod Immunol, pp.2010, 63[DOI]
44. Kheshtchin N, "The expression of Th1-and Th2-related chemokine receptors in women with recurrent miscarriage : the impact of lymphocyte immunotherapy", Am J Reprod Immunol, 64, pp.104~112 (2010)
45. Nakagawa K, "Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1", TH2 cell ratios, 2015, pp.73, 353~361
46. Ota K, "Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity", Hum Reprod, 29, pp.208~219 (2014)
47. Wegmann TG, "Placental immunotrophism : maternal T cells enhance placental growth and function", Am J Reprod Immunol Microbiol, 15, pp.67~69 (1987)
48. Li Y, "Tim-3 signaling in peripheral nk cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss", Sci Signal, 10, pp.eaah4323~ (2017)
49. Motedayyen H, "Human amniotic epithelial cells inhibit activation and pro-inflammatory cytokines production of naive CD4+ T cells from women with unexplained recurrent spontaneous abortion", Reprod Biol, 18, pp.182~188 (2018)
50. Tuomi T, "Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease", Diabetes, 42, pp.359~362 (1993)
51. Alecsandru D, "Pancreatic autoimmunity : an unknown etiology on patients with assisted reproductive techniques(ART)-recurrent reproductive failure", PLoS One, 13, pp.e0203446~ (2018)
52. Pedicino D, "Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus", J Diabetes Res, 2013, pp.184258~ (2013)
53. Yang Z, "The CD4(+)regulatory T-cells is decreased in adults with latent autoimmune diabetes", Diabetes Res Clin Pract, 76, pp.126~131 (2007)
54. Akesson C, "Altered natural killer(NK)cell frequency and phenotype in latent autoimmune diabetes in adults(LADA)prior to insulin deficiency", Clin Exp Immunol, 161, pp.48~56 (2010)
55. Buzzetti R, "High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes", Diabetes Care, 30, pp.932~938 (2007)
56. Ruuls SR, "Unlinking tumor necrosis factor biology from the major histocompatibility complex : lessons from human genetics and animal models", Am J Hum Genet, 65, pp.294~301 (1999)
57. Majetschak M, "Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients", Clin Diagn Lab Immunol, 9, pp.1205~1211 (2002)
58. Siwetz M, "TNF-α alters the inflammatory secretion profile of human first trimester placenta", Lab Invest, 96, pp.428~438 (2016)
59. Chen G, "TNF-R1 signaling : a beautiful pathway", Science, 296, pp.1634~1635 (2002)
60. Trussell J, "Cost effectiveness of contraceptives in the United States", Contraception, 79, pp.5~14 (2009)
61. Said EA, "Programmed death-1-induced interleukin-10production by monocytes impairs CD4+ T cell activation during HIV infection", Nat Med, 16, pp.452~459 (2010)
62. Alijotas-Reig J, "Potentiating maternal immune tolerance in pregnancy : a new challenging role for regulatory T cells", Placenta, 35, pp.241~248 (2014)
63. Götestam Skorpen C, "The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation", Ann Rheum Dis, 75, pp.795~810 (2016)
64. Flint J, "BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids", Rheumatology(Oxford), 55, pp.1693~1697 (2016)
65. Alijotas-Reig J, "Tumor necrosis factor-alpha and pregnancy: focus on biologics. An updated and comprehensive review", Clin Rev Allergy Immunol, 53, pp.40~53 (2017)
66. Kauma SW, "Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy", J Clin Endocrinol Metab, 73, pp.746~751 (1991)
67. Rahmati M, "Colony stimulating factors 1, 2, 3 and early pregnancy steps : from bench to bedside", J Reprod Immunol, 109, pp.1~6 (2015)
68. Makinoda S, "Granulocyte colony-stimulating factor(G-CSF)in the mechanism of human ovulation and its clinical usefulness", Curr Med Chem, 15, pp.604~613 (2008)
69. Mielcarek M, "Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products : a mechanism for monocyte-mediated suppression of T-cell proliferation", Blood, 92, pp.215~222 (1998)
70. Sugita K, "Granulocyte colony stimulation factor(G-CSF)suppresses interleukin(IL)-12and", or IL-2 induced interferon(IFN)-gamma production and cytotoxicity of decidual mononuclear cells, 2003, pp.50, 83~89
71. Moldenhauer LM, "GM-CSF is an essential regulator of T cell activation competence in uterine dendritic cells during early pregnancy in mice", J Immunol, 185, pp.7085~7096 (2010)
72. Wright EM, "Novel and unexpected functions of sglts", Physiology(Bethesda), 32, pp.435~443 (2017)
73. Faham S, "The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+", sugar symport, 2008, pp.321, 810~814
74. Salker MS, "Loss of endometrial sodium glucose cotransporter sglt1 is detrimental to embryo survival and fetal growth in pregnancy", Sci Rep, 7, pp.12612~ (2017)
75. Shibazaki T, "KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter(SGLT1), exhibits antidiabetic efficacy in rodent models", J Pharmacol Exp Ther, 342, pp.288~296 (2012)
76. Sharma P, "Sglt1 deficiency turns listeria infection into a lethal disease in mice", Cell Physiol Biochem, 42, pp.1358~1365 (2017)
77. Kitaya K, "Endometritis : new time, new concepts", Fertil Steril, 110, pp.344~350 (2018)
78. McQueen DB, "Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss", Fertil Steril, 104, pp.927~931 (2015)
79. Kitaya K, "Immunohistochemistrical and clinicopathological characterization of chronic endometritis", Am J Reprod Immunol, 66, pp.410~415 (2011)
80. Cicinelli E, "Chronic endometritis in patients with unexplained infertility : prevalence and effects of antibiotic treatment on spontaneous conception", Am J Reprod Immunol, 79, pp.e12782~ (2018)
81. Metwally M, "A proteomic analysis of the endometrium in obese and overweight women with recurrent miscarriage : preliminary evidence for an endometrial defect", Reprod Biol Endocrinol, 12, pp.75~ (2014)
82. Knochenhauer ES, "Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States : a prospective study", J Clin Endocrinol Metab, 83, pp.3078~3082 (1998)
83. Okon MA, "Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function", Fertil Steril, 69, pp.682~690 (1998)
84. Rahman TU, "Androgen-induced alterations in endometrial proteins crucial in recurrent miscarriages", Oncotarget, 9, pp.24627~24641 (2018)
85. Practice Committee of the American Society for Reproductive Medicine, "Current clinical irrelevance of luteal phase deficiency : a committee opinion", Fertil Steril, 103, pp.e27~e32 (2015)
86. Amrane S, "Endocrine causes of recurrent pregnancy loss", Semin Perinatol, 43, pp.80~83 (2019)
87. Meresman GF, "Apoptosis is increased and cell proliferation is decreased in out-of-phase endometria from infertile and recurrent abortion patients", Reprod Biol Endocrinol, 8, pp.126~ (2010)
88. Licht P, "Is human chorionic gonadotropin directly involved in the regulation of human implantation", Mol Cell Endocrinol, 269, pp.85~92 (2007)
89. Fox C, "Luteal phase HCG support for unexplained recurrent pregnancy loss-a low hanging fruit", Reprod Biomed Online, 34, pp.319~324 (2017)
90. Teichert A, "Quantification of the vitamin D receptor-coregulator interaction", Biochemistry, 48, pp.1454~1461 (2009)
91. Shahbazi M, "Expression profiling of vitamin D receptor in placenta, decidua and ovary of pregnant mice", Placenta, 32, pp.657~664 (2011)
92. Grzechocinska B, "The role of vitamin D in impaired fertility treatment", Neuroendocrinol Lett, 34, pp.756~762 (2013)
93. Lemire JM, "1 alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells", J Clin Invest, 74, pp.657~661 (1984)
94. Piccinni MP, "Role of hormone-controlled Th1-and Th2-type cytokines in successful pregnancy", J Neuroimmunol, 109, pp.30~33 (2000)
95. Adams JS, "Unexpected actions of vitamin D : new perspectives on the regulation of innate and adaptive immunity", Nat Clin Pract Endocrinol Metab, 4, pp.80~90 (2008)
96. Ji JL, "Immunological function of vitamin D during human pregnancy", Am J Reprod Immunol, 78, pp.e12716~ (2017)
97. Morales-Prieto DM, "MicroRNA expression profiles of trophoblastic cells", Placenta, 33, pp.725~734 (2012)
98. Bartel DP, "MicroRNAs : target recognition and regulatory functions", Cell, 136, pp.215~233 (2009)
99. Parveen F, "Recurrent miscarriage and micro-RNA among north Indian women", Reprod Sci, 22, pp.410~415 (2015)
100. Fluhr H, "Non-apoptotic fas-induced regulation of cytokines in undifferentiated and decidualized human endometrial stromal cells depends on caspase-activity", Mol Hum Reprod, 17, pp.127~134 (2011)
101. Carcagno AL, "E2F1-mediated upregulation of p19INK4d determines its periodic expression during cell cycle and regulates cellular proliferation", PLoS One, 6, pp.e21938~ (2011)
102. Jeon YJ, "Association study of microRNA polymorphisms with risk of idiopathic recurrent spontaneous abortion in Korean women", Gene, 494, pp.168~173 (2012)

관련 논문AI추천